Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Pediatric ALL, Tyrosine Kinase Inhibitors

Stephen Hunger

MD

🏢Children's Hospital of Philadelphia🌐USA

Professor and Chief

62
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Stephen Hunger at CHOP has contributed to pediatric ALL clinical research through Children's Oncology Group (COG) trials. His work on Philadelphia chromosome-positive ALL in children — establishing TKI (imatinib, dasatinib) addition to chemotherapy as transformative — and on characterizing and treating Ph-like ALL (BCR-ABL-like ALL without the BCR-ABL fusion) has been important for improving outcomes in high-risk pediatric leukemia.

Share:

🧪Research Fields 研究领域

pediatric ALL treatment COG
Philadelphia chromosome ALL
BCR-ABL ALL imatinib dasatinib
Ph-like ALL targeted therapy
pediatric leukemia clinical trials

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Stephen Hunger 的研究动态

Follow Stephen Hunger's research updates

留下邮箱,当我们发布与 Stephen Hunger(Children's Hospital of Philadelphia)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment